Replies to post #441473 on NorthWest Biotherapeutics Inc (NWBO)

[Know-Fear]

Agree with you response. Additionally: Also in the hope to have a one size fits all streamlined manufacturing approach which would suit BP more comfortably. There is trepidation (and there should be) in pivoting to personalized autologous produced therapies as its not their (BP) strong suit.

"There is a reason why the likes of BNTX/RHHBY, GRTS, GNCA and MRNA/MRK are selecting which neoantigens to target with their vaccines."

Because they think they are smarter than the immune system that has evolved over eons to pick up the perfect antigen set per patient per tumor. - I mean if you could match patients to multiple antigens and then follow back up with new antigens once those are down regulated. Seems like a lot of work instead of working with nature